Because p38 MAPK, ERK1/2, and MEK1/2 are the “Achilles heel” of tumor growth and cancer cell survival, targeting them helps negatively interrupt the typical proliferation environment of the cancer cell. This evidence concerns the gene MAP2K1 and cancer.